These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3139383)

  • 21. Misoprostol and ulcer prophylaxis.
    Upadhyay R; Taha AS; Sturrock RD; Russell RI
    Lancet; 1989 Jan; 1(8631):212-3. PubMed ID: 2563111
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapy for ulcers and erosions associated with nonsteroidal anti-inflammatory drugs.
    Freeman HJ
    Can J Gastroenterol; 1998; 12(8):537-9. PubMed ID: 10206732
    [No Abstract]   [Full Text] [Related]  

  • 23. [Duodenal ulcer and risk factors: influence of the treatment with misoprostol].
    Zaterka S; Marchese MA
    Arq Gastroenterol; 1987; 24(1):24-9. PubMed ID: 3130829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Misoprostol in the treatment of duodenal ulcer. A multicenter double-blind placebo-controlled study.
    Sontag SJ; Mazure PA; Pontes JF; Beker SG; Dajani EZ
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):159S-163S. PubMed ID: 3932049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G; Hopkins A; Akbar FA
    Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NSAIDs, misoprostol, and gastrointestinal bleeding.
    Shield MJ
    Lancet; 1991 May; 337(8751):1221-2. PubMed ID: 1673756
    [No Abstract]   [Full Text] [Related]  

  • 27. Chronic antral gastritis in duodenal ulcer. Natural history and treatment with prostaglandin E1.
    Hui WM; Lam SK; Ho J; Ng MM; Lui I; Lai CL; Lok AS; Lau WY; Poon GP; Choi S
    Gastroenterology; 1986 Nov; 91(5):1095-101. PubMed ID: 3093305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of endogenous gastric prostanoids in the pathogenesis and therapy of duodenal ulcer.
    Rachmilewitz D; Ligumsky M; Fich A; Goldin E; Eliakim A; Karmeli F
    Gastroenterology; 1986 Apr; 90(4):963-9. PubMed ID: 3081399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NSAIDs, misoprostol, and gastrointestinal bleeding.
    Bannwarth B; Schaeverbeke T; Dehais J; Doumayrou F
    Lancet; 1991 Apr; 337(8747):973-4. PubMed ID: 1678047
    [No Abstract]   [Full Text] [Related]  

  • 30. RUDER: interim evaluation of a 2-year, multicentre study of risk factors for duodenal ulcer relapse.
    Armstrong D; Blum AL; Arnold R; Classen M; Goebell H; Fischer M
    Z Gastroenterol Verh; 1991 Mar; 26():171-2. PubMed ID: 1714137
    [No Abstract]   [Full Text] [Related]  

  • 31. Prostaglandin E1 (misoprostol) overcomes the adverse effect of chronic cigarette smoking on duodenal ulcer healing.
    Lam SK; Lau WY; Choi TK; Lai CL; Lok AS; Hui WM; Ng MM; Choi SK
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):68S-74S. PubMed ID: 3080292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effects of nizatidine and misoprostol on peptic activity and gastric mucus].
    Grassi SA; Vianello F; Germanà B; Dal Santo P; Faggian D; Battaglia G; Plebani M; Di Mario F; Naccarato R
    Medicina (Firenze); 1990; 10(1):29-31. PubMed ID: 1974318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current directions in the treatment of gastric and duodenal ulcers].
    Fellus R
    Dakar Med; 1988; 33(1-4):42-4. PubMed ID: 2908566
    [No Abstract]   [Full Text] [Related]  

  • 34. Misoprostol and ulcer prophylaxis.
    Graham DY
    Lancet; 1988 Dec 24-31; 2(8626-8627):1484-5. PubMed ID: 2904589
    [No Abstract]   [Full Text] [Related]  

  • 35. [Gastroduodenal ulcer pathology and prostaglandins].
    Bellanger J; Pointereau-Bellanger A
    Ann Gastroenterol Hepatol (Paris); 1987 May; 23(3):129-34. PubMed ID: 3113323
    [No Abstract]   [Full Text] [Related]  

  • 36. Assessment of two new therapies for peptic ulcer disease: omeprazole and the prostaglandin analogues.
    McColl KE
    Dig Dis; 1988; 6(2):65-75. PubMed ID: 3129220
    [No Abstract]   [Full Text] [Related]  

  • 37. The association of ranitidine and sucralfate in the short-term treatment of duodenal ulcers, as compared to other forms of treatment.
    Magnanelli M; Belvisi A; Toninelli A; Matergi M; Camarri E
    Int J Tissue React; 1984; 6(2):189-93. PubMed ID: 6329980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcers. A multicenter double-blind study.
    Brand DL; Roufail WM; Thomson AB; Tapper EJ
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):147S-158S. PubMed ID: 3932048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intravenous omeprazole versus ranitidine in the treatment of hemorrhagic duodenal ulcer: a prospective randomized study].
    Cardi M; Muttillo IA; Amadori L; Barillari P; Sammartino P; Arnone F; Signorelli C; Bolognese A
    Ann Chir; 1997; 51(2):136-9. PubMed ID: 9297869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effectiveness and safety of 150 mg vs 300 mg ranitidine twice a day in duodenal ulcer].
    Schraier M; Jorge A; Pereyra JC; Carri J; Padua-Videla M; Hoffenberg P; Villalobos J; Orillac J; Waserstein M; Mendoza S
    Acta Gastroenterol Latinoam; 1993; 23(1):13-7. PubMed ID: 8237259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.